Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Work from home jobs offer flexibility and extra cash to help pay off debt. Explore opportunities that fit your schedule.
25,050 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
STRC dips to about $94.65, roughly 5% under its $100 par, renewing questions about Strategy's bitcoin strategy and th...
SpaceX’s public debut grabbed headlines, but history shows big early gains often fade. This guide explains why waitin...
A newly launched ETF that automates the wheel strategy is delivering about 12% yield as markets swing, offering a mec...
As market volatility lingers in 2026, the timing of Social Security claims tied to birthdays can dramatically alter m...
When a beverage maker expands beyond a single hero brand, the investment narrative changes. Celsius transformed its g...
Arm is venturing into in house silicon for AI workloads, a bold move that could redefine its growth path. This articl...
Canaccord Genuity boosts its price target on Plug Power to $4, citing early wins from Project Quantum Leap. The firm ...
A famous wall street futurist contends Starlink’s subscription revenue alone could underpin SpaceX’s multi-trillion-d...
Investing in AI stocks can feel like a fast-moving target. This article breaks down whether penguin solutions next st...
Choosing the right pharmaceutical ETF can feel like balancing income with growth. This guide compares VanEck's PPH an...
A high-profile investor move has eyes turning to a GLP-1 stock with big growth potential. Here’s what it means for ri...